CNTB is trading 5% up at $2.50, continuing a multi-day rally as the stock builds on strength established in late June.

  • The move appears to be a continuation of prior momentum rather than a response to new, discrete catalysts such as earnings, FDA updates, or M&A news.
  • Recent market attention has focused on analyst price targets and past volume spikes, signaling a sustained technical uptrend.
  • Shares have maintained a steady upward trajectory over several sessions, with today's gains further reinforcing the positive trend.